SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-066028
Filing Date
2015-11-16
Accepted
2015-11-16 16:19:00
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v423105_10q.htm 10-Q 376960
2 EXHIBIT 10.4 v423105_ex10-4.htm EX-10.4 48898
3 EXHIBIT 10.5 v423105_ex10-5.htm EX-10.5 16820
4 EXHIBIT 31.1 v423105_ex31-1.htm EX-31.1 7396
5 EXHIBIT 31.2 v423105_ex31-2.htm EX-31.2 7306
6 EXHIBIT 32.1 v423105_ex32-1.htm EX-32.1 4659
7 EXHIBIT 32.2 v423105_ex32-2.htm EX-32.2 4419
  Complete submission text file 0001144204-15-066028.txt   3625548

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT bcli-20150930.xml EX-101.INS 796232
9 XBRL TAXONOMY EXTENSION SCHEMA bcli-20150930.xsd EX-101.SCH 36969
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20150930_cal.xml EX-101.CAL 21705
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20150930_def.xml EX-101.DEF 173524
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20150930_lab.xml EX-101.LAB 246361
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20150930_pre.xml EX-101.PRE 195863
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 151234758
SIC: 2836 Biological Products, (No Diagnostic Substances)